Bliss GVS Pharma grants 553,000 employee stock options

Bliss GVS Pharma Limited announced today that its nomination and remuneration committee granted 553,000 stock options to eligible employees under the Bliss GVS Pharma Limited – Employee Stock Options Plan 2019. This decision, made on November 6, 2025, aligns with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The exercise price for these options is INR 43 per option/per share, determined by applying a 72.05% discount to the BSE last closing market price on November 4, 2025. The options will vest in four equal installments: 25% after 12, 24, 36, and 48 months from the grant date. Vested options are exercisable within six months, and the resulting equity shares will be subject to a six-month lock-in period from allotment.

The grant aims to harmonize the exercise price with earlier options, supporting the company's employee retention and motivation strategy. These details were provided to the National Stock Exchange of India Ltd. and BSE Limited for their records.